Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on July 6, 2006
J Am Soc Nephrol 17: 2315-2321, 2006
© 2006 American Society of Nephrology
doi: 10.1681/ASN.2006020105

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2006020105v1
17/8/2315    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carracedo, J.
Right arrow Articles by Aljama, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carracedo, J.
Right arrow Articles by Aljama, P.

Clinical Dialysis

On-Line Hemodiafiltration Reduces the Proinflammatory CD14+CD16+ Monocyte-Derived Dendritic Cells: A Prospective, Crossover Study

Julia Carracedo*, Ana Merino*, Sonia Nogueras*, Diana Carretero*, Isabel Berdud*, Rafael Ramírez*, Ciro Tetta{dagger}, Mariano Rodríguez*, Alejandro Martín-Malo* and Pedro Aljama*

* Unidad de Investigación, Servicio de Nefrología, Hospital Universitario Reina Sofía, Córdoba, Spain; and {dagger} Fresenius Medical Care, Research Extracorporeal Therapies, Bad Homburg, Germany

Address correspondence to: Dr. Rafael Ramírez, Unidad de Investigación, Hospital Universitario Reina Sofía, Avda Menendez Pidal S/N, Córdoba 14004, Spain. Phone: +34-957-010452; Fax: +34-957-010452; E-mail: manuelr.ramirez.sspa{at}juntadeandalucia.es

Received for publication February 1, 2006. Accepted for publication May 16, 2006.

It is not known whether high convective transport may have a role in modulating the chronic inflammation of hemodialysis (HD) patients. The aim of this study was to evaluate the effect of on-line hemodiafiltration (OL-HDF) on proinflammatory peripheral monocytes: Percentage of CD14+CD16+ cells and their telomere length and spontaneous or bacterial DNA-induced production of cytokines (TNF-{alpha} and IL-6). In a prospective, crossover study, 31 patients who were on high-flux HD (HF-HD) were evaluated. Patients underwent the following sequence of treatments (4 mo each): HF-HD (basal), OL-HDF (period 1), HF-HD (period 2), OL-HDF (period 3), and HF-HD (period 4). The dialysis characteristics were similar in the two modalities; the only difference was a higher convective transport in the OL-HDF than in the HF-HD. All patients who were on OL-HDF periods showed a significantly lower number of CD14+CD16+ cells than on HF-HD (18.5 ± 2.3 basal versus 13.6 ± 2.9 period 1 and 13.9 ± 2.3 period 3; P = 0.001). By contrast, HF-HD restored the number of CD14+CD16+ cells to the basal values (19.2 ± 2.8 and 18.6 ± 1.4, periods 2 and 4, respectively; NS). During OL-HDF periods, the reduction of CD14+CD16+ was paralleled by a decreased number of short telomere cells. Spontaneous or bacterial DNA-induced production of cytokines (TNF-{alpha} and IL-6) was increased in HF-HD as compared with OL-HDF. In conclusion, these results demonstrate that as compared with HF-HD, OL-HDF markedly reduces the number of proinflammatory CD14+CD16+ cells and the production of TNF-{alpha} and IL-6. Future studies are needed to assess the possible therapeutic effect of convective transport on chronic inflammation that is associated with HD.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
A. Merino, S. Nogueras, T. Garcia-Maceira, M. Rodriguez, A. Martin-Malo, R. Ramirez, J. Carracedo, and P. Aljama
Bacterial DNA and endothelial damage in haemodialysis patients
Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3635 - 3642.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
V. Panichi and C. Tetta
Reply
Nephrol. Dial. Transplant., September 1, 2008; 23(9): 3035 - 3035.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
V. Panichi, G. M. Rizza, S. Paoletti, R. Bigazzi, M. Aloisi, G. Barsotti, P. Rindi, G. Donati, A. Antonelli, E. Panicucci, et al.
Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study
Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2337 - 2343.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP